Abstract:Purpose: The NOEY2 gene mutations and protein expression in human breast cancers, adjacent breast tissues and breast benign lesions were analysed to explore the potential correlation between the mutation spectrum and breast cancer development and progression.Experimental design: The promoter, exon and intron regions of NOEY2 gene were amplified by polymerase chain reaction (PCR) with DNA extracted from 50 human breast cancer and corresponding adjacent breast tissues as well as 50 breast benign lesions, respectively. The PCR products were then sequenced and analysed. The effect Of mutations on the expression of NOEY2 protein by immunohistochemistry were proven as well.Results: Twenty-one of 50 (42%) breast cancer mutations were identified in promoter (I I cases) and exon 2 (seven cases on untranslation region and three on coding region) and 17 of 50 (34%) adjacent breast tissues (all were atypical hyperplasia lesions) occurred Mutations, including six promoter mutations and 11 exon 2 changes (10 cases on untranslation region and one on coding region). Interestingly, the mutations were identified in both breast cancers and the corresponding adjacent breast tissues collected from the same patient in seven of them. No mutation was identified in all benign breast tissues. Immunohistochemical analysis showed that two of 17 mutational adjacent breast tissue samples were NOEY2 immunoreaction negative, and in all 21 mutations of breast cancers five cases were of loss of NOEY2 expression. All mutations with immunoreaction negative factor were located at promoter and/or exon 2 coding region. NOEY2 gene mutations were not correlated with patient ages, histological types, tumour sizes, histological grades, clinical stages. axillary lymph node metastases or with the condition of hormone receptor (ER, PR) expression and HER2 amplification.Conclusions: The mutations of human NOEY2 were identified in human breast cancers and the corresponding adjacent breast tissues. The hot mutation spots were its promoter and exon 2 regions, and those Occurring at the exon2 coding region and part of the promoter may alter the expression of NOEY2. The presence of NOEY2 mutations in human breast cancer and early-stage lesions indicates that NOEY2 mutations may be partly associated with breast tumourigenesis. (C) 2009 Elsevier Ltd. All rights reserved.

VEGF Mrna Expression in Breast Cancer and Its Relation to Clinicopathological Parameters

Significance of Vascular Endothelial Growth Factor Expression and Its Correlation with Inducible Nitric Oxide Synthase in Gastric Cancer

NOEY2 Mutations in Primary Breast Cancers and Breast Hyperplasia

Expression and clinical significance of P16, P15,and VEGF proteins in primary epithelial ovarian carcinoma

Estrogen Receptor Beta Variants Mrna Expressions in Gastric Cancer Tissues and Association with Clinicopathologic Parameters

Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.

Clinical Relevance and Prognostic Value of the Neuronal Protein Neuroligin 2 in Breast Cancer

Elevated Expressions of SHP2 and GAB2 Correlated with VEGF in Eutopic and Ectopic Endometrium of Women with Ovarian Endometriosis.

Novel Anti-Angiogenic and Anti-Tumour Activities of the N-Terminal Domain of NOEY2 via Binding to VEGFR-2 in Ovarian Cancer

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

[Expression of Mrna Isoforms of Vascular Endothelial Growth Factor in Ovarian Carcinoma]

[Expressions of VEGF/VEGFRs and Activation of STATs in Ovarian Carcinoma].

Expression and Significance of Angiopoietin-2 in Gastric Cancer.

Expression and prognostic significance of the VEGFR-2 gene in human parenchyma of NSCLC

The expression of human antigen R and vascular endothelial growth factor-C and their significance in non-small cell lung cancer]

[Serum Levels of Endostatin and VEGF in Non-Small Cell Lung Cancer Patients and the Relationship with the Clinical Pathophysiological Characteristics].

[Study of Mrna Expression of Vascular Endothelial Growth Factor-(A, C, D) Genes and Its Effect on Prognosis of Breast Cancer].

[Expression Related to Vascular Endothelial Growth Factor C and Induced Nitride Oxide Synthesizase in Lymph Node Micrometastasis of Oral Squamous Cell Carcinoma].

Expression of C-erbB-2 and nm23 proteins in breast cancer and their clinical signifi cance

The Expression of ERβ Protein Correlates with Vascular Endothelial Growth Factor and Its Prognostic Significance in Human Breast Cancer

Expression of Androgen Receptor and Embryonic Stem Cell Associated Transcript 4 in Breast Cancer Patients with Over-Expression of Human Epidermal Growth Factor Receptor 2 and Their Clinical Significances